Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents.
Saved in:
| Title: | Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. |
|---|---|
| Authors: | Ronchetti AM, Isnard F, Buffet M, Coman T, Gorin NC, Coppo P, Garderet L, Malak S |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2013 May; Vol. 54 (5), pp. 1117-9. Date of Electronic Publication: 2013 Mar 08. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23035656 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ronchetti+AM%22">Ronchetti AM</searchLink><br /><searchLink fieldCode="AU" term="%22Isnard+F%22">Isnard F</searchLink><br /><searchLink fieldCode="AU" term="%22Buffet+M%22">Buffet M</searchLink><br /><searchLink fieldCode="AU" term="%22Coman+T%22">Coman T</searchLink><br /><searchLink fieldCode="AU" term="%22Gorin+NC%22">Gorin NC</searchLink><br /><searchLink fieldCode="AU" term="%22Coppo+P%22">Coppo P</searchLink><br /><searchLink fieldCode="AU" term="%22Garderet+L%22">Garderet L</searchLink><br /><searchLink fieldCode="AU" term="%22Malak+S%22">Malak S</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2013 May; Vol. 54 (5), pp. 1117-9. <i>Date of Electronic Publication: </i>2013 Mar 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23035656 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3109/10428194.2012.733879 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1117 Titles: – TitleFull: Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ronchetti AM – PersonEntity: Name: NameFull: Isnard F – PersonEntity: Name: NameFull: Buffet M – PersonEntity: Name: NameFull: Coman T – PersonEntity: Name: NameFull: Gorin NC – PersonEntity: Name: NameFull: Coppo P – PersonEntity: Name: NameFull: Garderet L – PersonEntity: Name: NameFull: Malak S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2013 May Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 54 – Type: issue Value: 5 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |
